NCT05342688

Brief Summary

The aim of the study is to examine associations between contextual interference (CI), engagement during practice and changes in upper limb motor performance among patients post-stroke. Fifty patients over the age of 18, after a stroke, in the sub-acute and early chronic stages who have weakness of the upper extremity and are treated in a rehabilitation center will be recruited. The study will include participation in five sessions: session 1 for baseline assessment, session 2-4 for practice of upper extremity functions, and session 5 for post intervention assessment. The intervention will include training of three items from the Wolf motor function test in random order (high CI group) or block order (low CI group). Outcomes of engagement will include the brain engagement index, heart rate variability and galvanic skin response. Outcomes of learning will include the pre-post change in performance of the wolf motor function selected items.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2020

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 9, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

November 9, 2021

Last Update Submit

April 18, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Brain Engagement Index

    EEG activity in the prefrontal cortex will be measured by MindWave mobile EEG headset.

    Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)

  • Change in time to complete each of three items of the Wolf Motor Function Test (WMFT)

    A maximum of 120 seconds is allowed. Any performance that exceeds 120 seconds is assigned 120 seconds.

    Pre-intervention session (first session), post-intervention session (session 5, 5-7 days following the pre-intervention session))

Secondary Outcomes (2)

  • Changes in Heart rate variability

    Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)

  • Changes in Galvanic Skin Response (GSR)

    Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)

Study Arms (2)

High contextual interference

EXPERIMENTAL

The intervention will involve practicing three items from the Wolf motor function test in random order during three sessions. Each item will be repeated 30 times in total.

Behavioral: Task-specific practice of upper extremity functions

Low contextual interference

ACTIVE COMPARATOR

The intervention will involve practicing three items from the Wolf motor function test in blocked order during three sessions. Each item will be repeated 30 times in total.

Behavioral: Task-specific practice of upper extremity functions

Interventions

The intervention will consist of training of items from the Wolf motor function test.

High contextual interferenceLow contextual interference

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Five days to 1-year post-stroke
  • Score of 11-60 on the Fugl-Meyer Assessment for upper extremity
  • The patient receives physical therapy and/or occupational therapy rehabilitation treatment

You may not qualify if:

  • A history of neurological diseases other than stroke or orthopedics conditions that impair upper extremity function
  • Pain that prevents active movement of the upper extremity
  • Hemodynamic instability
  • Cognitive decline and language difficulties that do not allow understanding of instructions and cooperation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reut Medical Center

Tel Aviv, Israel

RECRUITING

Central Study Contacts

Michal Kafri, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Masking description: The outcome assessor will be blind to the group assignment of the participants. Participants and the investigator who deliver the intervention will be aware of group assignment because it is inherent to the type of practice they receive and deliver respectively.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will be a randomized controlled trial with a pre-post design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 9, 2021

First Posted

April 25, 2022

Study Start

January 1, 2020

Primary Completion

January 1, 2023

Study Completion

June 1, 2023

Last Updated

April 25, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations